Proteolysis at the extracellular matrix interface: Molecular architects and regulators in health and disease
The FEBS Journal · 2026-07 · 293 (13) · 3758-3787
DOI: 10.1111/febs.70514 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 02.04.2026. Verfasst von David Jurnečka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular and Structural Biology, Jožef Stefan Institute, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Extracellular Matrix, Proteolysis, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 355 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Slovenian Research and Innovation Agency.
Abstract (Originalsprache)
The extracellular matrix (ECM) is a dynamic and multifaceted scaffold that orchestrates tissue architecture, signalling and cell behaviour in multicellular organisms. Its function arises from the interplay between composition, three‐dimensional organisation and mechanics, together with the tightly regulated activity of proteolytic enzymes and cell surface receptors. Cluster of differentiation (CD) molecules function as regulators at the cell–matrix interface by directing adhesion, migration, immune surveillance and the localisation of proteases within pericellular niches. Cathepsins, along with matrix metalloproteinases, ADAM and ADAMTS sheddases, orchestrate ECM turnover, basement membrane and interstitial remodelling, and the generation of bioactive fragments that influence cell fate and signalling. Disruption of these networks shifts tissues towards fibrosis, defective development, chronic inflammation, vascular pathologies and cancer. This review integrates foundational principles with recent discoveries to map the molecular architects and regulators of the matrix in health and disease, emphasising how composition and mechanics interact with protease‐driven turnover and receptor‐mediated sensing. Finally, we outline emerging therapeutic strategies that restore matrix balance through targeted modulation of protease activity, engineering of ECM‐mimetic scaffolds with programmable mechanics and degradability, and tuning of CD‐mediated signalling to promote regeneration and resolution.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular and Structural Biology, Jožef Stefan Institute, Ljubljana, Slovenia.
- Jožef Stefan International Postgraduate School, Ljubljana, Slovenia.
- Faculty of Chemistry and Chemical Technology, University of Ljubljana, Slovenia.
ORCID-Profile: Boris Turk
Förderung
- Slovenian Research and Innovation Agency
Zitieren
APA
Jurnečka, D., Hrovatin, M., Bokalj, B., & Turk, B. (2026). Proteolysis at the extracellular matrix interface: Molecular architects and regulators in health and disease. The FEBS Journal, 293(13), 3758-3787. https://doi.org/10.1111/febs.70514
Vancouver
Jurnečka D, Hrovatin M, Bokalj B, Turk B. Proteolysis at the extracellular matrix interface: Molecular architects and regulators in health and disease. The FEBS Journal. 2026;293(13):3758-3787. doi:10.1111/febs.70514
BibTeX
@article{Jurneka2026,
author = {Jurnečka, David and Hrovatin, Matija and Bokalj, Bor and Turk, Boris},
title = {Proteolysis at the extracellular matrix interface: Molecular architects and regulators in health and disease},
journal = {The FEBS Journal},
year = {2026},
volume = {293},
number = {13},
pages = {3758--3787},
doi = {10.1111/febs.70514}
}
EUVIMED